Sign in
4

Changes in Ownership

DiaMedica Therapeutics Inc. Filed Acc 0001235802-24-000051

Options or other derivatives

  • Chief Commercial Officer acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cundari Dominic R Chief Commercial Officer 2024-06-01 Grant or award · Stock Option (right to buy) +15,000 15,000 D
Loading xslF345X05/primary_doc.xml…